Advanced search
Publication Cover
Cell Cycle Volume 18, 2019 - Issue 15
Submit an article Journal homepage
1,408
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Identification and validation of microRNAs that synergize with miR-34a – a basis for combinatorial microRNA therapeutics

Esteban A. Orellanaa Department of Biological Sciences, Purdue University, West Lafayette, IN, USA;b Stem Cell Program, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0003-4369-9416View further author information
ORCID Icon,
Chennan Lia Department of Biological Sciences, Purdue University, West Lafayette, IN, USAView further author information
,
Alexa Lisevicka Department of Biological Sciences, Purdue University, West Lafayette, IN, USAView further author information
&
Andrea L. Kasinskia Department of Biological Sciences, Purdue University, West Lafayette, IN, USA;c Purdue Center for Cancer Research, Purdue University, West Lafayette, IN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9602-7827View further author information
ORCID Icon
Pages 1798-1811 | Received 03 May 2019, Accepted 14 Jun 2019, Published online: 01 Jul 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shu Zhou, Jinjun Li, XiaoNa Zhang & Wen Xiong. (2022) MicroRNA-124 modulates neuroinflammation in acute methanol poisoning rats via targeting Krüppel-like factor-6. Bioengineered 13:5, pages 13507-13519.
Read now
Kenneth K.W. To, Winnie Fong, Christy W.S. Tong, Mingxia Wu, Wei Yan & William C.S. Cho. (2020) Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments. Expert Opinion on Drug Discovery 15:1, pages 63-83.
Read now

Articles from other publishers (10)

Neha Datta, Charlotte Johnson, Dina Kao, Pratik Gurnani, Cameron Alexander, Christos Polytarchou & Tanya M. Monaghan. (2023) MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacological Research 194, pages 106870.
Crossref
Gavin M. Traber & Ai-Ming Yu. (2023) RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. Journal of Pharmacology and Experimental Therapeutics 384:1, pages 133-154.
Crossref
Fatimat Kipkeeva, Tatyana Muzaffarova, Alexandra Korotaeva, Danzan Mansorunov, Pavel Apanovich, Maxim Nikulin, Olga Malikhova, Ivan Stilidi & Alexander Karpukhin. (2022) The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer. International Journal of Molecular Sciences 23:16, pages 9324.
Crossref
Tao Jiang & Zhong-Bing Luo. (2022) LOC102724163 promotes breast cancer cell proliferation and invasion by stimulating MUC19 expression. Oncology Letters 23:3.
Crossref
Li Zuo, Xiaoli Li, Yue Tan, Hailong Zhu & Mi Xiao. (2021) Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis. Journal of Ovarian Research 14:1.
Crossref
Qianghua Xu, Xiao Chen & Bin Chen. (2021) MicroRNA‑3148 inhibits glioma by decreasing DCUN1D1 and inhibiting the NF‑kB pathway . Experimental and Therapeutic Medicine 23:1.
Crossref
Ahmed M Abdelaal & Andrea L Kasinski. (2021) Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases. NAR Cancer 3:3.
Crossref
A.S. Pal, M. Bains, A. Agredo & A.L. Kasinski. (2021) Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer. Biochemical Pharmacology 189, pages 114154.
Crossref
Hui Yang, Yuting Chen, Wei Xu, Ming Shao, Jixiang Deng, Shanshan Xu, Xing Gao, Shiyang Guan, Jinian Wang, Shengqian Xu, Zongwen Shuai & Faming Pan. (2021) Epigenetics of ankylosing spondylitis: Recent developments. International Journal of Rheumatic Diseases 24:4, pages 487-493.
Crossref
Shantanu Gupta, Daner A. Silveira, Florencia M. Barbé-Tuana & José Carlos M. Mombach. (2020) Integrative data modeling from lung and lymphatic cancer predicts functional roles for miR-34a and miR-16 in cell fate regulation. Scientific Reports 10:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.